These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 7345340

  • 21. [Parameters of cellular immunity in subjects with bronchial squamous cell tumors].
    Vietti Ramus G, Tartaglino B, Cesano L, Revello F, Barbalonga A.
    Minerva Med; 1983 Apr 14; 74(16):879-87. PubMed ID: 6601781
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
    Dini MM, Lenzi L, Faiferman I.
    Am J Reprod Immunol (1980); 1983 Jun 14; 3(4):188-90. PubMed ID: 6881415
    [Abstract] [Full Text] [Related]

  • 23. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA, Doering DL, Bosscher JR, Day TG, Rao CV, Owens K, Kelly B, Goldsmith J.
    Gynecol Oncol; 1994 Nov 14; 55(2):169-73. PubMed ID: 7959279
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Humoral immunity in patients with carcinoma of the uterine cervix--effects of radiation therapy.
    Juranić Z, Vucković-Dekić L, Durbaba M.
    Neoplasma; 1993 Nov 14; 40(5):297-300. PubMed ID: 8272158
    [Abstract] [Full Text] [Related]

  • 26. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 14; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of therapeutic measures in carcinoma of the mouth on the immunologic response capacity of those patients].
    Hyckel P, Metzner G, Haroske D, Müller P.
    Dtsch Z Mund Kiefer Gesichtschir; 1985 Jan 14; 9(6):469-74. PubMed ID: 3869491
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The characteristics of proliferation activity in squamous metaplasia and reserve cell hyperplasia of uterine cervix].
    Tsanava RM, Burkadze GM, Chkhobadze MD, Berdzenishvili BR.
    Georgian Med News; 2006 Oct 14; (139):44-6. PubMed ID: 17077465
    [Abstract] [Full Text] [Related]

  • 34. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
    Kwon GY, Ha H, Ahn G, Park SY, Huh SJ, Park W.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1150-6. PubMed ID: 17692475
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.
    Gynecol Oncol; 1995 Jun 15; 57(3):366-75. PubMed ID: 7774840
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.